Navigation Links
Their immune cells, fighting your cancer
Date:9/19/2007

IMMUNE cells from cancer-resistant people are to be injected into those with cancer to help fight the disease. Zheng Cui at Wake Forest University of Medicine in Winston-Salem, North Carolina, and his colleagues have received permission from the US Food and Drug Administration (FDA) to screen people for their ability to ward off cancer. Immune cells from the best cancer fighters will be given to cancer patients, after being matched for blood type. All of us have some ability to fight cancer, via immune cells called NK cells which can identify and kill tumour cells, although the extent of these cells influence is not known. But Cui has now discovered that a much larger population of immune cells called granulocytes can also kill cancer and that the effectiveness of these cells varies from person to person.

Cui took blood samples from more than 100 people and mixed their granulocytes with cervical cancer cells. While granulocytes from one individual killed around 97 per cent of cancer cells within 24 hours, those from another healthy individual only killed around 2 per cent of cancer cells. Average cancer-killing ability appeared to be lower in adults over the age of 50 and even lower in people with cancer. It also fell when people were stressed, and at certain times of the year. Nobody seems to have any cancer-killing ability during the winter months from November to April, says Cui, who presented preliminary results at the Strategies for Engineered Negligible Senescence meeting in Cambridge, UK, earlier this month.

Initial evidence suggests it may be possible to transfer the ability to fight off cancer between people. Granulocytes are already taken from donors and given to some patients whose immune systems have been depleted by chemotherapy, for example, though not to treat cancer directly. And last year Cui successfully treated a range of different cancers in mice by injecting them with granulocytes from a strain of mice that are completely resistant to cancer (Proceedings of the National Academy of Sciences, DOI: 10.1073/pnas.0602382103).

Cui hopes to begin human trials next summer in the US, when the immune systems of potential granulocyte donors will be at their peak.

The concept of using immune cells from one person to fight cancer in another person is a very hot topic right now, says John Gribben, a cancer immunologist at Cancer Research UKs experimental medicine centre at St Bartholomews Hospital, London.

However, if Cui plans to try this therapy in people, he will have to be very careful, Gribben says. If theyre using live cells there is a theoretical risk of graft-versus-host disease, which can prove fatal. This is a particular problem in patients with depleted immune systems, where transfused cells may proliferate and take over the hosts immune system, eventually destroying cells in the bone marrow. Cui says he is working with the FDA to minimise this risk.


'/>"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-611-1210
New Scientist
Source:Eurekalert

Related medicine news :

1. Starvation in pregnant women can cause heart disease to their children
2. Antibiotics losing their power against acne
3. False beliefs could cost cancer patients their lives
4. People suffering from Alzheimer’s: can they take decisions about their treatment
5. Worms Learn To Choose Their Diet
6. Diabetics and their babies
7. Pregnant smokers could harm their child
8. Healthcare Professionals Might Want To Rethink Their Dress Code
9. Diabetics Can Now Be Able To Control Both Blood Sugar And Their Weight
10. Mother’s Diet Could Prevent Cancer In Their Unborn Children
11. Common Thyroid Problems In Women May Lower Their Risk Of Developing Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... TX (PRWEB) , ... May 27, 2017 , ... Hate visiting the dentist? You should ... you'll need to take care of your teeth at home. Here are some dental tips ... after meals. Keep a small toothbrush in your work desk or a locker at school ...
(Date:5/27/2017)... ... 2017 , ... Most us are familiar with the sound of occasional popping ... Osteoarthritis Initiative shows that certain people who experience consistent joint popping, grating and ... doctors the opportunity to treat patients before the problem becomes pronounced, potentially hedging off ...
(Date:5/26/2017)... , ... May 26, 2017 , ... ... at Boston CEO 2017 on May 30th and 31st at The Four Seasons ... for leading executives in the life sciences, offering exclusive access to key decision ...
(Date:5/26/2017)... , ... May 26, 2017 , ... ... of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface ... browser-based interface for diagnostic device operations. With this platform, initializing devices and importing ...
(Date:5/26/2017)... ... 26, 2017 , ... via seating is proud to partner ... chair specifically designed for clinical areas. Genie Copper Mesh is a crossover chair ... to provide customers with a game changing chair that is affordably priced,” Chas ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 9, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... today announced it has earned a spot on ... The Company was ranked among 500 U.S. employers as ... Healthcare Equipment and Services. The annual ... anonymous, independent survey of over 30,000 employees across 25 ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/8/2017)... , May 8, 2017 MACRA replaces ... from fee for service reimbursement. Black Book Research crowdsource-surveyed ... 1.       The Market for MIPS Compliance Technology ... of physician practices with 3 or more clinicians seek ... by Q4. "Given the magnitude of the changes, the ...
Breaking Medicine Technology: